Technology Expertise
- Liver MPS platforms with primary and iPSC-derived cells
- PK and Hepatotxicity modeling
- Organoid/MPS as drug screening platforms
Disease Focus
- Hepatotoxicity
- Pharmacokinetics
The Computational, Organoid, and Microphysiological Systems Initiative